LMF Acquisition Opportunities Inc (ICUCW)
$0.02
$0.00
(-0.61%)
As on 04-Sep-2026 14:21EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
LMF Acquisition Opportunities Inc (ICUCW)
| 43.4 | -18.6 | -29.3 | -64.9 | 9.0 | -- | -- |
|
BSE Sensex
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
LMF Acquisition Opportunities Inc (ICUCW)
| -45.1 | -32.0 | -66.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout LMF Acquisition Opportunities Inc (ICUCW)
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic... device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado. Read more
-
CEO, President & Executive Director
Mr. Eric Schlorff
-
CEO, President & Executive Director
Mr. Eric Schlorff
-
Headquarters
Denver, CO
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for LMF Acquisition Opportunities Inc (ICUCW)
What is the current share price of LMF Acquisition Opportunities Inc (ICUCW) Today?
The share price of LMF Acquisition Opportunities Inc (ICUCW) is $0.02 (NASDAQ) as of 04-Sep-2026 14:21 EDT. LMF Acquisition Opportunities Inc (ICUCW) has given a return of 9.03% in the last 3 years.
What is the current PB & PE ratio of LMF Acquisition Opportunities Inc (ICUCW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.02 |
0.02 |
2024 |
0.00 |
0.00 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
2021 |
-- |
-- |
What is the 52 Week High and Low of LMF Acquisition Opportunities Inc (ICUCW)?
The 52-week high and low of LMF Acquisition Opportunities Inc (ICUCW) are Rs 0.08 and Rs 0.00 as of 06-Sep-2026.
What is the market cap of LMF Acquisition Opportunities Inc (ICUCW)?
LMF Acquisition Opportunities Inc (ICUCW) has a market capitalisation of -- as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in LMF Acquisition Opportunities Inc (ICUCW)?
Before investing in LMF Acquisition Opportunities Inc (ICUCW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.